APC/Cyanine7 Anti-Human CD38 Antibody
英诺赛图(InnoCyto)的 APC/Cyanine7 Anti-Human CD38 Antibody(克隆 HIT2) 为鼠源 IgG1 单克隆抗体,靶向 CD38(别名 gp45 等),APC/Cyanine7 标记(633 nm 红色激光激发),适用于流式细胞术。提供 25 tests、100 tests 规格,目录价 ¥1,559 起,仅供科研使用(RUO)。
01产品图片

02产品简介
英诺赛图(InnoCyto)的 APC/Cyanine7 Anti-Human CD38 Antibody(克隆 HIT2) 为鼠源 IgG1 单克隆抗体,靶向 CD38(别名 gp45 等),APC/Cyanine7 标记(633 nm 红色激光激发),适用于流式细胞术。提供 25 tests、100 tests 规格,目录价 ¥1,559 起,仅供科研使用(RUO)。
03产品介绍
规格与货号
101023 | 25 tests | ¥1,559
109215 | 25 tests | ¥1,559
109216 | 100 tests | ¥3,729
Product Details
Regulatory Status|RUO
Protein Concentration|Supplied at a lot-specific concentration.
Storage & Handling|The antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
Recommended Usage|For flow cytometric staining, it is recommended to use 5 µL of this reagent per 0.5-1.0 million cells in a 100 µL volume. Optimal reagent performance should be determined by titration for each specific application. APC/Cyanine7 has an excitation max at 650 nm and an emission max at 774 nm.
See All Formats|Clone HIT2
Background Information
CD38 is a multifunctional cell surface glycoprotein that plays important roles in immune cell signaling, metabolism, and cell-cell interactions. It is widely expressed on hematopoietic cells, including plasma cells, activated T and B lymphocytes, natural killer (NK) cells, monocytes, and dendritic cells, with expression levels varying depending on cell type and activation state. CD38 is also found on non-hematopoietic tissues, reflecting its broad biological significance.
Structurally, CD38 is a type II transmembrane protein with a short N-terminal cytoplasmic tail, a single transmembrane domain, and a large extracellular C-terminal domain that contains its enzymatic active site. Unlike many CD molecules that function solely as receptors or adhesion molecules, CD38 exhibits ectoenzyme activity. It acts primarily as a NAD⁺ glycohydrolase, catalyzing the conversion of nicotinamide adenine dinucleotide (NAD⁺) into metabolites such as cyclic ADP-ribose (cADPR), ADP-ribose, and nicotinic acid adenine dinucleotide phosphate (NAADP).
Functionally, CD38 regulates intracellular calcium signaling through the generation of cADPR and NAADP, which act as second messengers controlling calcium release from intracellular stores. Through this mechanism, CD38 influences cell activation, proliferation, migration, cytokine secretion, and survival. CD38 also participates in cell-cell interactions by associating with other surface molecules and contributing to immunological synapse formation. CD38 has several functional ligands, most notably CD31 (PECAM-1), which mediates adhesion and signaling interactions between immune cells and endothelial cells. In addition, CD38’s enzymatic substrates, such as NAD⁺, serve as functional ligands that drive its metabolic activity. These interactions integrate immune signaling with cellular metabolism, particularly in inflamed or metabolically stressed environments.
Aberrant CD38 expression and activity are implicated in multiple diseases. CD38 is highly expressed on malignant plasma cells in multiple myeloma and on certain leukemias and lymphomas, making it a valuable diagnostic marker. Elevated CD38 expression is also associated with chronic inflammation, immune exhaustion, and aging, partly due to its role in NAD⁺ depletion. In autoimmune and infectious diseases, altered CD38 expression reflects immune activation and disease progression.
CD38 is a major therapeutic target, particularly in hematologic malignancies. Monoclonal antibodies targeting CD38 have transformed the treatment of multiple myeloma by inducing tumor cell death through antibody-dependent cellular cytotoxicity, complement activation, and immune modulation. Beyond oncology, strategies aimed at modulating CD38 enzymatic activity are being explored to restore NAD⁺ levels and improve immune or metabolic function, highlighting CD38’s growing importance in both immunotherapy and metabolic intervention.
Data Sheets
Human peripheral blood lymphocytes were stained with APC/Cyanine7 Anti-Human CD38 clone HIT2 (color-filled histogram) or an isotype control (gray histogram).
04完整参数表
参数由厂商资料整理,采购前请以最终报价单与技术协议为准。
05荣誉与资质
该品牌暂未上传荣誉证书与资质文件。以下是平台可核验的公开信息,未上传项如实标注,不做推断。
- 营业执照未上传
- 品牌授权未上传
- 产品检测报告未上传
- 会员身份
- 收费会员
- 经营身份
- 原厂
- 成立年份
- 2020 年
- 所在地
- 上海
- 收录条目
- 1865 个
- 平台核验
- 平台代管
06品牌与供应商
InnoCyto(上海英诺赛图生物科技有限公司)致力于通过开发高质量细胞分析试剂,加速科学发现进程。公司为研究人员提供细胞层面探索所需的工具,推动免疫学、肿瘤学等多领域的研究创新。 核心团队拥有丰富的行业经验,曾参与全球头部生命科学公司的标杆项目搭建,深刻理解工业界与学术研究的前沿需求。试剂从设计之初即以精确性、一致性、高性能为核心标准,让科学家能把精力集中在最核心的研究工作上。 公司将深厚的科学积累与对品质的严格承诺相结合,力争成为全球研究人员信赖的合作伙伴。产品线覆盖经验证的一抗与二抗、同型对照、生物类似药抗体、重组蛋白、细胞因子、免疫检测试剂盒及配套试剂,并提供重组蛋白/抗体表达与标记偶联服务。
品牌资料由厂商公开信息与授权渠道核对整理;条目参数与价格以最终报价单为准。
07同类条目
同一子类内的条目才具备可比性。跨子类比较参数通常没有意义。
08同品牌其他条目
上海英诺赛图 在本目录共 1865 个条目,除本条外还有:
科研在线(TeleVM). APC/Cyanine7 Anti-Human CD38 Antibody(109215)[EB/OL]. 产品目录, 2026-11-12. https://www.suprotek.cn/products/item/apc-cyanine7-anti-human-cd38-antibody-109215.html.
TeleVM. (2026, November 12). APC/Cyanine7 Anti-Human CD38 Antibody(109215). 产品目录. https://www.suprotek.cn/products/item/apc-cyanine7-anti-human-cd38-antibody-109215.html
@misc{biocsp_item_apc_cyanine7_anti_human_cd38_antibody_109215,
title = {APC/Cyanine7 Anti-Human CD38 Antibody(109215)},
author = {{科研在线}},
year = {2026},
howpublished = {产品目录},
note = {更新于 2026-11-12,产品目录},
url = {https://www.suprotek.cn/products/item/apc-cyanine7-anti-human-cd38-antibody-109215.html}
}
GB/T 7714 用于中文论文与报告;APA 7 用于英文期刊;BibTeX 可直接导入 Zotero、EndNote 或 LaTeX。
许可:CC BY-NC 4.0 · 转载注明来源